Biotricity Inc. Faces Potential Nasdaq Delisting Threat
Company Announcements

Biotricity Inc. Faces Potential Nasdaq Delisting Threat

Biotricity Inc (BTCY) has released an update to notify the public and investors about listing compliance status.

Biotricity Inc. was notified by Nasdaq that its Market Value of Listed Securities (MVLS) fell below the $35 million requirement, granting them until January 29, 2024, to comply. Failing to meet this condition, the company was informed of a potential delisting on February 8, 2024. Biotricity Inc. plans to appeal this decision and will present a plan to regain compliance with the MVLS requirement at the Nasdaq Hearings Panel, which will postpone the suspension and delisting process.

For further insights into BTCY stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TheFlyBiotricity: Advancements to ‘propel the company towards profitability’ by Q4 end
TheFlyBiotricity announces inclusion as supplier to major medical system
TheFlyBiotricity launches cardiac monitoring pilot program wih hospital system
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App